Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Atrion CorpATRI37.994.583.3525.415.23%9.44%0.00$456.71$1,702.81-$459.92

Detail of Atrion Corp

 
CEO
Mr. David A. Battat
Employees
667
Industry
Medical Instruments & Supplies
Sector
Healthcare
Market cap
$809M

Company details

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$176.67M
Cost of goods (CoG)
-$117.01M
Gross profit (GP)
$59.66M
Operating expense (OE)
-$28.74M
Research and development (R&D)
-$4.84M
General and administrative (G&A)
-$23.90M
Operating income (OI)
$21.25M
Other income expense (OIE)
-$245,000.00
Pretax income (PI)
$21.58M
Tax (TAX)
-$2.86M
Net income (NI)
$18.72M
Atrion Corp
ATRI • XNGS • US
$459.92
+74.82 (19.43%)
Stock vs Industry average
  • Industry average

Dividend yield
0.96%
Trailing annual dividend rate
$8.80
Payout ratio
123.60%
EPS
$12.11
Margin profit
6.92%
52 week low
$308.299988
52 week high
$495.519989
50-day simple moving average
$0.00
200-day simple moving average
$456.71
Percent held by insiders
23.37%
Percent held by institutions
71.86%
Dividend yield
1.91%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
ATRI +15.16%
eps change
ATRI -19.70%